GP73 is reported to enhance Smad2/3 phosphorylation via activation of TGF-β1 and promote EMT via upregulation of EMT marker expression while SB431542 specifically inhibits Smad2/3 phosphorylation and reverses EMT in HCC [168]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.